Coverage dated September 9, 2025

Wegovy and Ozempic maker to cut 9,000 jobs amid stiff competition from Eli Lilly

Headline from KTVZ Bend

By Ana Nicolaci da Costa, CNN London (CNN) — Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in the obesity market. The Danish company has been battling it out with US rival Eli Lilly, with each developing newer medicines to …

KTVZ Bend's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Reports & sources

7 articles, oldest first.

  1. FOX Business

    Ozempic maker to cut thousands of jobs (opens FOX Business)

    Published

    FOX Business's feed description

    Novo Nordisk plans to cut 9,000 jobs globally, including 5,000 in Denmark, as the Ozempic and Wegovy maker faces increased competition from Eli Lilly in the obesity market.

  2. KTVZ Bend

    Wegovy and Ozempic maker to cut 9,000 jobs amid stiff competition from Eli Lilly (opens KTVZ Bend)

    Published

    KTVZ Bend's feed description

    By Ana Nicolaci da Costa, CNN London (CNN) — Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in the obesity market. The Danish company has been battling it out with US rival Eli Lilly, with each developing newer medicines to …

  3. New York Post

    Wegovy-maker Novo Nordisk to cut 9,000 jobs in restructuring (opens New York Post)

    Published

    New York Post's feed description

    Wegovy-maker Novo Nordisk will cut 9,000 jobs, or about 11.5% of its workforce, in a restructuring to save $1.26 billion annually, it said on Wednesday, as it battles rising pressure from US rival Eli Lilly

  4. Digital Journal

    Ozempic maker Novo Nordisk to cut 9,000 global jobs (opens Digital Journal)

    Published

    Digital Journal's feed description

    Danish pharmaceutical giant Novo Nordisk announced Wednesday that it would cut 11 percent of its workforce, as the maker of Ozempic and Wegovy faces

  5. Newsweek

    Ozempic maker slashes jobs amid rising competition (opens Newsweek)

    Published

    Newsweek's feed description

    Novo Nordisk cited a "more competitive and consumer-driven" market while announcing the elimination of 9,000 roles.

  6. The Guardian

    Wegovy maker Novo Nordisk to cut 9,000 jobs amid increased competition (opens The Guardian)

    Published

    The Guardian's feed description

    Danish manufacturer of weight-loss and diabetes drugs under pressure from US rival Eli Lilly

  7. Al Jazeera

    Wegovy maker Novo Nordisk to slash thousands of jobs (opens Al Jazeera)

    Published

    Al Jazeera's feed description

    The layoffs come amid sluggish sales as competition heats up in the weight-loss drug market.

Wegovy and Ozempic maker to cut 9,000 jobs amid stiff competition from Eli Lilly | Since Then